key: cord-0839036-inzg763r
authors: Acharya, Suchi; Saxena, Apoorv; John, B. M.; Tewari, Vishal Vishnu
title: Atypical Multisystem Inflammatory Syndrome in Children (MIS-C)
date: 2021-05-01
journal: Indian J Pediatr
DOI: 10.1007/s12098-021-03774-w
sha: c749002b4bcddd972040aada1cf81fae16b83d76
doc_id: 839036
cord_uid: inzg763r

nan

To the Editor: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with several hyperinflammatory conditions, some of which include children presenting with Kawasaki-like disease. This has been termed 'multisystem inflammatory syndrome in children' (MIS-C) [1] . We report a case of a 6-y-old child with an atypical presentation of MIS-C.

This previously healthy boy was admitted with intermittent fever of 10 d duration and erythema multiforme like rash initially involving both legs and subsequently spreading over whole body, however sparing the face and mucosa. On admission, he was hemodynamically stable and systemic examination was normal. He became afebrile within 24 h of admission on symptomatic therapy. His initial workup revealed RT-PCR positive for SARS-CoV-2, anemia (Hb 9.1 g/dL), neutrophilic leucocytosis (15,600/cumm, p 79%), thrombocytosis (6.3 lacs/cumm) and elevated D-dimer (1074 ng/mL); however, other markers of inflammation like erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and serum ferritin were normal. The echocardiography showed left main coronary artery dilatation (z score + 3.6). He was diagnosed as a case of MIS-C according to Centre for Disease Control and Prevention (CDC) criteria [2] . He was managed with intravenous immunoglobulins (IVIG) at 2 g/kg and low-dose aspirin with complete recovery over next 12 wk.

MIS-C is a clinicopathologic condition encompassing a spectrum, which mimics complete or incomplete Kawasaki disease (KD), toxic shock syndrome, hemophagocytic lymphohistiocytosis and/or macrophage activation syndrome [3] . Few MIS-C patients even without KD-like symptoms also developed coronary artery aneurysm [4] .

Our case was atypical since the child had become afebrile within 24 h of admission and did not have elevated markers of inflammation except D-dimer. In the pre-COVID scenario, in the absence of D-dimer testing, the child would not have been subjected to echocardiography. Further, the child had coronary artery changes even in the absence of evidence of significant hyperinflammation thus highlighting the importance of keeping a low threshold for cardiac evaluation in the current scenario.

Conflict of Interest None.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review

Emergency preparedness and response: health alert network

Hyperinflammatory shock in children during COVID-19 pandemic

Multisystem inflammatory syndrome in US children and adolescents

Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations